ArticleMolecular therapy. Methods & clinical development2023

Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma.

Nigel Blackwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.